Nanexa AB (FRA:40M) Inventory Turnover: -208.50 (As of Mar. 2026)

What is Nanexa AB Inventory Turnover?

Nanexa AB FRA:40M -0.66% 48 Inventory Turnover is -208.50 as of Mar. 2026. GuruFocus rates FRA:40M with a GF Score™ of 48/100 and a GF Value™ of €0.17 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Nanexa AB's Cost of Goods Sold for the three months ended in Mar. 2026 was €-0.42 Mil. Nanexa AB's Average Total Inventories for the quarter that ended in Mar. 2026 was €0.00 Mil. Nanexa AB's Inventory Turnover for the quarter that ended in Mar. 2026 was -208.50.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nanexa AB's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.01.

Nanexa AB (FRA:40M) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nanexa AB's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	0.002	/	-0.417	*	365 / 4
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nanexa AB's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	0.002	/	0.152
	=	0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Nanexa AB Inventory Turnover Related Terms

Nanexa AB Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Nanexa AB's Inventory Turnover can be seen below:

Nanexa AB Inventory Turnover Chart

Nanexa AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

0.00

Nanexa AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															-87.20	-19.51	-11.63	-33.38	-208.50

48GF Score

Nanexa AB FRA:40M

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nanexa AB Inventory Turnover Calculation

Nanexa AB's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	-1.818	/ (	(0	+	0)	/	1 )
=	-1.818	/	0
=	N/A

Nanexa AB's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	-0.417	/ (	(0	+	0.002)	/	1 )
=	-0.417	/	0.002
=	-208.50

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of -208.50 mean?

Nanexa AB (FRA:40M) has a Inventory Turnover of -208.50 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Nanexa AB and its competitors.

Is Nanexa AB's Inventory Turnover too high?

Nanexa AB's current Inventory Turnover is -208.50. Overall, Nanexa AB has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Nanexa AB's Inventory Turnover compare to ZTS and UTHR?

Nanexa AB's Inventory Turnover of -208.50 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Nanexa AB and its competitors. Nanexa AB's current Inventory Turnover is -208.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nanexa AB stock overvalued right now?

Based on GuruFocus' analysis, Nanexa AB (FRA:40M) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.17, compared to a current price of €0.30 — trading 76.8% above its estimated fair value. The current Inventory Turnover is -208.50. Nanexa AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Nanexa AB (FRA:40M), the current Inventory Turnover is -208.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanexa AB (FRA:40M) Overvalued in 2026?

Based on GuruFocus' analysis, Nanexa AB stock appears to be overvalued. The current stock price of €0.30 is trading 76.8% above its estimated GF Value™ of €0.17. GuruFocus considers Nanexa AB to be Significantly Overvalued.

Key valuation signals for FRA:40M:

Inventory Turnover: -208.50
GF Value™: €0.17 vs. price of €0.30 (76.8% above fair value)
GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the FRA:40M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanexa AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:EQL OSTO:DICOT OSTO:ENZY OSTO:CINPHA OSTO:ORX OSTO:MOB OSTO:KLAR XSAT:ACUC OSTO:VIVE OSTO:NEWBRY XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges NANEXA:Sweden

Address Virdings Alle 32B, Uppsala, SWE, 75450

Website https://www.nanexa.com

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its products and also has collaboration agreements with several pharma companies, among others AstraZeneca. Geographically, the company derives maximum revenue from Nordic countries, while it also has its presence in Europe (excluding the Nordic countries), North America, and Asia.

48GF Score

Get the complete analysis for FRA:40M

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30

Price

€0.17

GF Value

View FRA:40M Analysis

See Inventory Turnover data for all stocks →